CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.225
  • 0.0000.00%
15min DelayPost Market Jul 26 16:00 ET
55.15MMarket Cap-5769P/E (TTM)

Helix BioPharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
34.44%1.82M
-27.02%902K
-21.01%1.25M
4.74%6.33M
91.93%2.14M
4.15%1.36M
-35.83%1.24M
-6.54%1.59M
-33.86%6.04M
-50.60%1.12M
Selling and administrative expenses
-8.11%68K
-1.37%72K
1,192.31%168K
-49.75%299K
97.22%142K
-36.75%74K
-66.36%73K
-94.20%13K
-64.71%595K
-89.02%72K
-General and administrative expense
-8.11%68K
-1.37%72K
1,192.31%168K
-49.75%299K
97.22%142K
-36.75%74K
-66.36%73K
-94.20%13K
-64.71%595K
-89.02%72K
Research and development costs
36.99%1.49M
-33.62%683K
-27.00%949K
16.22%5.28M
122.10%1.86M
15.44%1.08M
-31.67%1.03M
4.08%1.3M
-22.72%4.54M
-52.90%837K
Other operating expenses
36.36%270K
9.70%147K
-50.37%135K
-17.20%746K
-32.52%139K
-19.51%198K
-33.99%134K
21.97%272K
-42.35%901K
216.38%206K
Operating profit
-34.44%-1.82M
27.02%-902K
21.01%-1.25M
-4.74%-6.33M
-91.93%-2.14M
-4.15%-1.36M
35.83%-1.24M
6.54%-1.59M
33.86%-6.04M
50.60%-1.12M
Net non-operating interest income (expenses)
0
-135.71%-5K
66.67%10K
335.71%33K
400.00%3K
600.00%10K
255.56%14K
300.00%6K
96.03%-14K
99.71%-1K
Non-operating interest income
-85.71%2K
0.00%17K
30.00%13K
1,075.00%47K
50.00%6K
--14K
--17K
--10K
--4K
500.00%4K
Non-operating interest expense
-50.00%2K
633.33%22K
-25.00%3K
-22.22%14K
-40.00%3K
100.00%4K
-66.67%3K
33.33%4K
20.00%18K
25.00%5K
Other net income (expenses)
-188.89%-8K
-86.49%5K
53.85%-12K
100.59%3K
93.73%-17K
121.95%9K
144.05%37K
77.19%-26K
-466.67%-510K
-58.48%-271K
Gain on sale of security
-300.00%-8K
-86.49%5K
53.85%-12K
77.78%-2K
-666.67%-17K
-63.64%4K
242.31%37K
-966.67%-26K
-117.31%-9K
110.34%3K
Special income (charges)
--0
----
----
--5K
--0
--5K
----
----
--0
--0
-Gain on sale of property,plant,equipment
--0
----
----
--5K
--0
--5K
----
----
--0
--0
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
-252.82%-501K
---274K
Income before tax
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.17%-6.29M
-55.30%-2.15M
0.59%-1.34M
41.31%-1.19M
11.47%-1.61M
31.45%-6.56M
49.95%-1.39M
Income tax
Earnings from equity interest net of tax
Net income
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
11.47%-1.61M
18.35%-6.56M
49.96%-1.39M
Net income continuous operations
-36.95%-1.83M
23.88%-902K
21.87%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
11.47%-1.61M
31.45%-6.56M
49.96%-1.39M
Noncontrolling interests
Net income attributable to the company
-36.95%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
11.42%-1.61M
18.35%-6.56M
49.96%-1.39M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-36.95%-1.83M
23.88%-902K
21.92%-1.25M
4.16%-6.29M
-55.41%-2.15M
0.59%-1.34M
41.31%-1.19M
11.42%-1.61M
18.35%-6.56M
49.96%-1.39M
Diluted earnings per share
14.10%-0.0086
57.02%-0.0043
0.00%-0.01
25.00%-0.03
-0.02
0.00%-0.01
0.00%-0.01
0.00%-0.01
33.33%-0.04
0
Basic earnings per share
14.10%-0.0086
57.02%-0.0043
0.00%-0.01
25.00%-0.03
-0.02
0.00%-0.01
0.00%-0.01
0.00%-0.01
33.33%-0.04
0
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 34.44%1.82M-27.02%902K-21.01%1.25M4.74%6.33M91.93%2.14M4.15%1.36M-35.83%1.24M-6.54%1.59M-33.86%6.04M-50.60%1.12M
Selling and administrative expenses -8.11%68K-1.37%72K1,192.31%168K-49.75%299K97.22%142K-36.75%74K-66.36%73K-94.20%13K-64.71%595K-89.02%72K
-General and administrative expense -8.11%68K-1.37%72K1,192.31%168K-49.75%299K97.22%142K-36.75%74K-66.36%73K-94.20%13K-64.71%595K-89.02%72K
Research and development costs 36.99%1.49M-33.62%683K-27.00%949K16.22%5.28M122.10%1.86M15.44%1.08M-31.67%1.03M4.08%1.3M-22.72%4.54M-52.90%837K
Other operating expenses 36.36%270K9.70%147K-50.37%135K-17.20%746K-32.52%139K-19.51%198K-33.99%134K21.97%272K-42.35%901K216.38%206K
Operating profit -34.44%-1.82M27.02%-902K21.01%-1.25M-4.74%-6.33M-91.93%-2.14M-4.15%-1.36M35.83%-1.24M6.54%-1.59M33.86%-6.04M50.60%-1.12M
Net non-operating interest income (expenses) 0-135.71%-5K66.67%10K335.71%33K400.00%3K600.00%10K255.56%14K300.00%6K96.03%-14K99.71%-1K
Non-operating interest income -85.71%2K0.00%17K30.00%13K1,075.00%47K50.00%6K--14K--17K--10K--4K500.00%4K
Non-operating interest expense -50.00%2K633.33%22K-25.00%3K-22.22%14K-40.00%3K100.00%4K-66.67%3K33.33%4K20.00%18K25.00%5K
Other net income (expenses) -188.89%-8K-86.49%5K53.85%-12K100.59%3K93.73%-17K121.95%9K144.05%37K77.19%-26K-466.67%-510K-58.48%-271K
Gain on sale of security -300.00%-8K-86.49%5K53.85%-12K77.78%-2K-666.67%-17K-63.64%4K242.31%37K-966.67%-26K-117.31%-9K110.34%3K
Special income (charges) --0----------5K--0--5K----------0--0
-Gain on sale of property,plant,equipment --0----------5K--0--5K----------0--0
Other non-operating income (expenses) ---------------------------------252.82%-501K---274K
Income before tax -36.95%-1.83M23.88%-902K21.87%-1.25M4.17%-6.29M-55.30%-2.15M0.59%-1.34M41.31%-1.19M11.47%-1.61M31.45%-6.56M49.95%-1.39M
Income tax
Earnings from equity interest net of tax
Net income -36.95%-1.83M23.88%-902K21.87%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M11.47%-1.61M18.35%-6.56M49.96%-1.39M
Net income continuous operations -36.95%-1.83M23.88%-902K21.87%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M11.47%-1.61M31.45%-6.56M49.96%-1.39M
Noncontrolling interests
Net income attributable to the company -36.95%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M11.42%-1.61M18.35%-6.56M49.96%-1.39M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -36.95%-1.83M23.88%-902K21.92%-1.25M4.16%-6.29M-55.41%-2.15M0.59%-1.34M41.31%-1.19M11.42%-1.61M18.35%-6.56M49.96%-1.39M
Diluted earnings per share 14.10%-0.008657.02%-0.00430.00%-0.0125.00%-0.03-0.020.00%-0.010.00%-0.010.00%-0.0133.33%-0.040
Basic earnings per share 14.10%-0.008657.02%-0.00430.00%-0.0125.00%-0.03-0.020.00%-0.010.00%-0.010.00%-0.0133.33%-0.040
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg